Insights from immuno-oncology: The Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

Paolo Antonio Ascierto, Bernard Fox, Walter Urba, Ana Carrizosa Anderson, Michael B. Atkins, Ernest C. Borden, Julie Brahmer, Lisa H. Butterfield, Alessandra Cesano, Daniel Chen, Tanja De Gruijl, Robert O. Dillman, Charles G. Drake, Leisha A. Emens, Thomas F. Gajewski, James L. Gulley, F. Stephen Hodi, Patrick Hwu, David Kaufman, Howard KaufmanMichael Lotze, Douglas G. McNeel, Kim Margolin, Francesco Marincola, Michael J. Mastrangelo, Marcela V. Maus, David R. Parkinson, Pedro J. Romero, Paul M. Sondel, Stefani Spranger, Mario Sznol, George J. Weiner, Jon M. Wiggington, Jeffrey S. Weber

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Article numbere000878
JournalJournal for immunotherapy of cancer
Volume8
Issue number1
DOIs
StatePublished - Apr 16 2020

Keywords

  • immunomodulation
  • inflammation mediators

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this